Featured Article Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients
Year: 2016
Type: article
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2470890654
